DZUNG X NGUYEN OD
Prescription History 1205826708
Optometrist in Oak Lawn, IL
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for DZUNG X NGUYEN OD, an active Optometrist specialist practicing in Oak Lawn, IL. Our medical registry currently tracks 23 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 1,954 documented patient claims. Among these therapy options, the most frequently utilized medication is Latanoprost, which accounts for 699 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2024)Rx (2024) | Avg Cost per FillCost / Fill | Vs. Other IL PrescribersVs. IL Avg |
|---|---|---|---|
| Latanoprost | 699 | $12.52 | ▲ More than typical |
About Latanoprost: Latanoprost is used to treat high pressure inside the eye due to glaucoma (open angle type) or other eye diseases (such as ocular hypertension). Show more ▾ It is similar to a natural chemical in the body (prostaglandin) and works by regulating the flow of fluid within the eye which results in lower pressure. Lowering high pressure inside the eye helps to prevent blindness. A prostaglandin F analog used to treat OCULAR HYPERTENSION in patients with GLAUCOMA. In 2024, this provider wrote 699 Medicare prescriptions for Latanoprost, about 4.6 times the volume of the typical Illinois prescriber of this medication (150.7). Medicare paid an average of $12.52 per fill, versus $12.04 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average IL prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 1,265.9 30-Day Fills standardized to 30-day supplies 35,944 Days of Medication total across all patients in 2024 | |||
| Timolol Maleate | 198 | $9.25▼ below IL avg | ▲ More than typical |
About Timolol Maleate: This medication is used to treat high pressure inside the eye due to glaucoma (open angle-type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye helps to prevent blindness. This medication works by decreasing the amount of fluid within the eye. Timolol belongs to a class of drugs known as beta-blockers. A beta-adrenergic antagonist that is similar in action to PROPRANOLOL; the levo-isomer is more active. Timolol has been proposed as an anti-hypertensive, anti-arrhythmic, anti-angina, and anti-glaucoma agent. It is also used in the treatment of MIGRAINE DISORDERS and tremor. In 2024, this provider wrote 198 Medicare prescriptions for Timolol Maleate, about 2.5 times the volume of the typical Illinois prescriber of this medication (78.6). Medicare paid an average of $9.25 per fill, versus $15.88 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average IL prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the IL average for this medication. 310 30-Day Fills standardized to 30-day supplies 8,847 Days of Medication total across all patients in 2024 | |||
| Brimonidine Tartrate | 181 | $80.98 | ▲ More than typical |
About Brimonidine Tartrate: This medication is used to treat open-angle glaucoma or high fluid pressure in the eye. Show more ▾ Lowering high fluid pressure in the eye reduces the risk of vision loss, nerve damage, or blindness. This medication lowers pressure by allowing better fluid drainage from within the eye and also by reducing the amount of fluid formed in the eye. It is known as an alpha agonist. This drug is not recommended for use in children less than 2 years of age due to an increased risk of serious side effects such as very slowed breathing. Ask the doctor or pharmacist for details. A quinoxaline derivative and ADRENERGIC ALHPA-2 RECEPTOR AGONIST that is used to manage INTRAOCULAR PRESSURE associated with OPEN-ANGLE GLAUCOMA and OCULAR HYPERTENSION. In 2024, this provider wrote 181 Medicare prescriptions for Brimonidine Tartrate, about 2.5 times the volume of the typical Illinois prescriber of this medication (73.6). Medicare paid an average of $80.98 per fill, versus $32.64 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average IL prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 306.9 30-Day Fills standardized to 30-day supplies 8,880 Days of Medication total across all patients in 2024 | |||
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 166 | $15.87▼ below IL avg | ▲ More than typical |
About Dorzolamide-Timolol: This product contains two drugs used to treat high pressure inside the eye due to glaucoma (open angle-type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye helps to prevent blindness. This medication works by decreasing the amount of fluid within the eye. Timolol belongs to a class of drugs known as beta-blockers, and dorzolamide belongs to a class of drugs known as carbonic anhydrase inhibitors. In 2024, this provider wrote 166 Medicare prescriptions for Dorzolamide-Timolol, about 1.8 times the volume of the typical Illinois prescriber of this medication (94.6). Medicare paid an average of $15.87 per fill, versus $16.88 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average IL prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the IL average for this medication. 327.4 30-Day Fills standardized to 30-day supplies 9,822 Days of Medication total across all patients in 2024 | |||
| Alphagan PBrimonidine Tartrate | 73 | $325.88▼ below IL avg | ▲ More than typical |
About Alphagan P: This medication is used to treat open-angle glaucoma or high fluid pressure in the eye. Show more ▾ Lowering high fluid pressure in the eye reduces the risk of vision loss, nerve damage, or blindness. This medication lowers pressure by allowing better fluid drainage from within the eye and also by reducing the amount of fluid formed in the eye. It is known as an alpha agonist. This drug is not recommended for use in children less than 2 years of age due to an increased risk of serious side effects such as very slowed breathing. Ask the doctor or pharmacist for details. A quinoxaline derivative and ADRENERGIC ALHPA-2 RECEPTOR AGONIST that is used to manage INTRAOCULAR PRESSURE associated with OPEN-ANGLE GLAUCOMA and OCULAR HYPERTENSION. In 2024, this provider wrote 73 Medicare prescriptions for Alphagan P, about 2.4 times the volume of the typical Illinois prescriber of this medication (29.9). Medicare paid an average of $325.88 per fill, versus $389.34 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average IL prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the IL average for this medication. 105 30-Day Fills standardized to 30-day supplies 3,021 Days of Medication total across all patients in 2024 | |||
| LumiganBimatoprost | 73 | $446.44▼ below IL avg | ▲ More than typical |
About Lumigan: Bimatoprost is used to treat high pressure inside the eye due to glaucoma (open-angle type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye can help prevent blindness. This medication works by regulating the flow of fluid within the eye to maintain a normal pressure. A cloprostenol-derived amide that is used as an ANTIHYPERTENSIVE AGENT in the treatment of OPEN-ANGLE GLAUCOMA and OCULAR HYPERTENSION. In 2024, this provider wrote 73 Medicare prescriptions for Lumigan, about 1.4 times the volume of the typical Illinois prescriber of this medication (52.5). Medicare paid an average of $446.44 per fill, versus $486.31 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average IL prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the IL average for this medication. 117.8 30-Day Fills standardized to 30-day supplies 3,382 Days of Medication total across all patients in 2024 | |||
| Prednisolone Acetate | 69 | $47.59 | ▼ Less than typical |
About Prednisolone Acetate: This medication is used to treat certain eye conditions due to inflammation or injury. Show more ▾ Prednisolone works by relieving symptoms such as swelling, redness, and itching. It belongs to a class of drugs known as corticosteroids. A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states. In 2024, this provider wrote 69 Medicare prescriptions for Prednisolone Acetate, about half the volume of the typical Illinois prescriber of this medication (122.9). Medicare paid an average of $47.59 per fill, versus $37.81 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average IL prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 96.5 30-Day Fills standardized to 30-day supplies 2,409 Days of Medication total across all patients in 2024 | |||
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 61 | $8.43▼ below IL avg | ▲ More than typical |
About Neomycin-Polymyxin-Dexameth: This medication is used to treat conditions involving swelling (inflammation) of the eyes and to treat or prevent bacterial eye infections. Show more ▾ This product contains neomycin and polymyxin, antibiotics that work by stopping the growth of bacteria. It also contains dexamethasone, an anti-inflammatory corticosteroid that works by reducing swelling. This medication treats/prevents only bacterial eye infections. It will not work for other types of eye infections and may worsen them (such as infections caused by viruses, fungi, mycobacteria). Unnecessary use or overuse of any antibiotic can lead to its decreased effectiveness. In 2024, this provider wrote 61 Medicare prescriptions for Neomycin-Polymyxin-Dexameth, about 1.4 times the volume of the typical Illinois prescriber of this medication (42.2). Medicare paid an average of $8.43 per fill, versus $10.28 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average IL prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the IL average for this medication. 61 30-Day Fills standardized to 30-day supplies 805 Days of Medication total across all patients in 2024 | |||
| Azelastine Hcl | 46 | $29.64 | ▲ More than typical |
About Azelastine Hcl: This medication is used to relieve nasal symptoms such as runny/itching/stuffy nose, sneezing, and post-nasal drip caused by allergies or other conditions. Show more ▾ Azelastine belongs to a class of drugs known as antihistamines. It works by blocking certain natural substances called histamines that are responsible for nasal symptoms. Azeptin is azelastine hydrochloride; structure; eye drop formulation effective in relieving symptoms of allergic conjunctivitis; do not confuse with 5-loxin which is an extract of Boswellia. In 2024, this provider wrote 46 Medicare prescriptions for Azelastine Hcl, about 1.3 times the volume of the typical Illinois prescriber of this medication (36). Medicare paid an average of $29.64 per fill, versus $28.67 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average IL prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 69.2 30-Day Fills standardized to 30-day supplies 2,044 Days of Medication total across all patients in 2024 | |||
| ErythromycinErythromycin Base | 36 | $14.93 | ▼ Less than typical |
About Erythromycin: This medication is used to treat certain eye infections (such as conjunctivitis). Show more ▾ It is also used to prevent certain eye infections in newborns. It belongs to a class of drugs known as macrolide antibiotics. Erythromycin works by stopping the growth of bacteria. This medication treats only bacterial eye infections. It will not work for other types of eye infections. Unnecessary use or misuse of any antibiotic can lead to its decreased effectiveness. A bacteriostatic antibiotic macrolide produced by Streptomyces erythreus. Erythromycin A is considered its major active component. In sensitive organisms, it inhibits protein synthesis by binding to 50S ribosomal subunits. This binding process inhibits peptidyl transferase activity and interferes with translocation of amino acids during translation and assembly of proteins. In 2024, this provider wrote 36 Medicare prescriptions for Erythromycin, about 74% of the volume of the typical Illinois prescriber of this medication (48.9). Medicare paid an average of $14.93 per fill, versus $12.57 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average IL prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 36 30-Day Fills standardized to 30-day supplies 293 Days of Medication total across all patients in 2024 | |||
| RhopressaNetarsudil Mesylate | 34 | $457.02▼ below IL avg | ▼ Less than typical |
About Rhopressa: Netarsudil is used to treat high pressure inside the eye due to certain eye conditions (such as open-angle glaucoma, ocular hypertension). Show more ▾ This medication is thought to work by increasing the flow of fluid out of the eye. This helps lower pressure inside the eye. Lowering high pressure inside the eye can help prevent loss of vision or blindness. A Rho kinase inhibitor with norepinephrine transport inhibitory activity that reduces production of aqueous humor. In 2024, this provider wrote 34 Medicare prescriptions for Rhopressa, about 72% of the volume of the typical Illinois prescriber of this medication (47.2). Medicare paid an average of $457.02 per fill, versus $502.35 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average IL prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the IL average for this medication. 47.2 30-Day Fills standardized to 30-day supplies 1,302 Days of Medication total across all patients in 2024 | |||
| Doxycycline Hyclate | 31 | $10.24▼ below IL avg | ≈ Typical |
About Doxycycline Hyclate: This medication is used to treat a wide variety of bacterial infections, including those that cause acne. Show more ▾ This medication is also used to prevent malaria. This medication is known as a tetracycline antibiotic. It works by stopping the growth of bacteria. This antibiotic treats only bacterial infections. It will not work for viral infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections. A synthetic tetracycline derivative with similar antimicrobial activity. In 2024, this provider wrote 31 Medicare prescriptions for Doxycycline Hyclate, about the same volume as the typical Illinois prescriber of this medication (30.2). Medicare paid an average of $10.24 per fill, versus $12.92 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average IL prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the IL average for this medication. 31 30-Day Fills standardized to 30-day supplies 431 Days of Medication total across all patients in 2024 | |||
| Dorzolamide Hcl | 31 | $19.43 | ▼ Less than typical |
About Dorzolamide Hcl: Dorzolamide is used to treat high pressure inside the eye due to glaucoma (open angle-type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye helps to prevent blindness. This medication works by decreasing the amount of fluid within the eye. It belongs to a class of drugs known as carbonic anhydrase inhibitors. Topically effective ocular hypotensive carbonic anhydrase inhibitor. In 2024, this provider wrote 31 Medicare prescriptions for Dorzolamide Hcl, about half the volume of the typical Illinois prescriber of this medication (57.8). Medicare paid an average of $19.43 per fill, versus $16.82 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average IL prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 68.4 30-Day Fills standardized to 30-day supplies 2,052 Days of Medication total across all patients in 2024 | |||
| Travoprost | 31 | $174.02 | ≈ Typical |
About Travoprost: Travoprost is used to treat high pressure inside the eye due to glaucoma (open-angle type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye can help prevent blindness. This medication works by regulating the flow of fluid within the eye to maintain a normal pressure. A cloprostenol derivative that is used as an ANTIHYPERTENSIVE AGENT in the treatment of OPEN-ANGLE GLAUCOMA and OCULAR HYPERTENSION. In 2024, this provider wrote 31 Medicare prescriptions for Travoprost, about the same volume as the typical Illinois prescriber of this medication (31.2). Medicare paid an average of $174.02 per fill, versus $164.57 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average IL prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 52.9 30-Day Fills standardized to 30-day supplies 1,551 Days of Medication total across all patients in 2024 | |||
| SimbrinzaBrinzolamide/Brimonidine Tart | 29 | $213.51▼ below IL avg | ≈ Typical |
About Simbrinza: This product contains two medications used to treat high pressure in the eye due to glaucoma (open-angle glaucoma-type) or a certain other eye disease (ocular hypertension). Show more ▾ Lowering high pressure in the eye reduces the risk of vision loss, nerve damage, or blindness. This product contains brinzolamide and brimonidine. These two medications work together to decrease the amount of fluid within the eye. Brinzolamide belongs to a class of drugs known as carbonic anhydrase inhibitors. Brimonidine belongs to a class of drugs known as alpha agonists. This product is not recommended for use in children younger than 2 years of age due to an increased risk of serious side effects such as very slowed breathing. Ask the doctor or pharmacist for details. In 2024, this provider wrote 29 Medicare prescriptions for Simbrinza, about the same volume as the typical Illinois prescriber of this medication (29.8). Medicare paid an average of $213.51 per fill, versus $269.21 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average IL prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the IL average for this medication. 36.3 30-Day Fills standardized to 30-day supplies 1,027 Days of Medication total across all patients in 2024 | |||
| Tobramycin-DexamethasoneTobramycin/Dexamethasone | 29 | $49.23 | ≈ Typical |
About Tobramycin-Dexamethasone: This medication is used to treat or prevent eye infections. Show more ▾ This medication contains two drugs. Tobramycin belongs to a class of drugs called aminoglycoside antibiotics. It works by stopping the growth of bacteria. Dexamethasone belongs to a class of drugs called corticosteroids. It works by reducing swelling. This medication treats/prevents only bacterial eye infections. It will not work for other types of eye infections. Unnecessary use or overuse of any antibiotic can lead to its decreased effectiveness. In 2024, this provider wrote 29 Medicare prescriptions for Tobramycin-Dexamethasone, about the same volume as the typical Illinois prescriber of this medication (29). Medicare paid an average of $49.23 per fill, versus $46.82 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average IL prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 29.5 30-Day Fills standardized to 30-day supplies 644 Days of Medication total across all patients in 2024 | |||
| XiidraLifitegrast | 29 | $806.58▼ below IL avg | ≈ Typical |
About Xiidra: This medication is used to treat dry eye disease. Show more ▾ An LFA-1 (LYMPHOCYTE FUNCTION-ASSOCIATED ANTIGEN-1) antagonist that is used in the treatment of DRY EYE SYNDROMES. In 2024, this provider wrote 29 Medicare prescriptions for Xiidra, about 1.2 times the volume of the typical Illinois prescriber of this medication (25.2). Medicare paid an average of $806.58 per fill, versus $1,069.40 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average IL prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the IL average for this medication. 35 30-Day Fills standardized to 30-day supplies 1,050 Days of Medication total across all patients in 2024 | |||
| Ofloxacin | 28 | $15.13 | ▼ Less than typical |
About Ofloxacin: This medication is used to treat eye infections. Show more ▾ Ofloxacin belongs to a class of drugs called quinolone antibiotics. It works by stopping the growth of bacteria. This medication treats only bacterial eye infections. It will not work for other types of eye infections. Unnecessary use or overuse of any antibiotic can lead to its decreased effectiveness. A synthetic fluoroquinolone antibacterial agent that inhibits the supercoiling activity of bacterial DNA GYRASE, halting DNA REPLICATION. In 2024, this provider wrote 28 Medicare prescriptions for Ofloxacin, about half the volume of the typical Illinois prescriber of this medication (63.7). Medicare paid an average of $15.13 per fill, versus $13.25 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average IL prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 31.6 30-Day Fills standardized to 30-day supplies 781 Days of Medication total across all patients in 2024 | |||
| RestasisCyclosporine | 26 | $879.64▼ below IL avg | ▼ Less than typical |
About Restasis: Cyclosporine eye drops are used to treat a certain type of dry eyes. Show more ▾ They work by increasing the amount of tears you make. A cyclic undecapeptide from an extract of soil fungi. It is a powerful immunosupressant with a specific action on T-lymphocytes. It is used for the prophylaxis of graft rejection in organ and tissue transplantation. (From Martindale, The Extra Pharmacopoeia, 30th ed). In 2024, this provider wrote 26 Medicare prescriptions for Restasis, about 73% of the volume of the typical Illinois prescriber of this medication (35.5). Medicare paid an average of $879.64 per fill, versus $958.55 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average IL prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the IL average for this medication. 36 30-Day Fills standardized to 30-day supplies 1,080 Days of Medication total across all patients in 2024 | |||
| CombiganBrimonidine Tartrate/Timolol | 23 | $323.51▼ below IL avg | ▼ Less than typical |
About Combigan: This combination medication is used to treat high pressure inside the eye due to glaucoma (open-angle type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye helps to prevent blindness. This product contains brimonidine and timolol. These medications are used together when 1 drug is not controlling the pressure inside the eye. Brimonidine works by allowing better fluid drainage from within the eye and also by decreasing the amount of fluid formed in the eye. It belongs to a class of drugs known as alpha agonists. Timolol is thought to work by decreasing the amount of fluid formed in the eye. Timolol belongs to a class of drugs known as beta blockers. This medication is not recommended for use in children less than 2 years old due to an increased risk of serious side effects. Ask the doctor or pharmacist for more details. A pharmaceutical preparation of brimonidine tartrate and timolol maleate. The combined ADRENERGIC ALPHA2 RECEPTOR AGONIST and ADRENERGIC BETA-ANTAGONIST activity of these drugs reduce INTRAOCULAR PRESSURE in GLAUCOMA patients. In 2024, this provider wrote 23 Medicare prescriptions for Combigan, about 74% of the volume of the typical Illinois prescriber of this medication (31.3). Medicare paid an average of $323.51 per fill, versus $369.37 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average IL prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the IL average for this medication. 38.9 30-Day Fills standardized to 30-day supplies 1,162 Days of Medication total across all patients in 2024 | |||
| VyzultaLatanoprostene Bunod | 22 | $451.83▼ below IL avg | ▼ Less than typical |
About Vyzulta: Latanoprostene bunod is used to treat high pressure inside the eye due to glaucoma (open-angle type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye can help prevent blindness. This medication works by controlling the flow of fluid within the eye to maintain a normal pressure. A lanatoprost prodrug, nitric oxide donor, and PGF2alpha agonist. In 2024, this provider wrote 22 Medicare prescriptions for Vyzulta, about half the volume of the typical Illinois prescriber of this medication (38.3). Medicare paid an average of $451.83 per fill, versus $455.58 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average IL prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the IL average for this medication. 38.1 30-Day Fills standardized to 30-day supplies 1,117 Days of Medication total across all patients in 2024 | |||
| Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol | 20 | $129.43▼ below IL avg | ▼ Less than typical |
About Brimonidine Tartrate-Timolol: This combination medication is used to treat high pressure inside the eye due to glaucoma (open-angle type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye helps to prevent blindness. This product contains brimonidine and timolol. These medications are used together when 1 drug is not controlling the pressure inside the eye. Brimonidine works by allowing better fluid drainage from within the eye and also by decreasing the amount of fluid formed in the eye. It belongs to a class of drugs known as alpha agonists. Timolol is thought to work by decreasing the amount of fluid formed in the eye. Timolol belongs to a class of drugs known as beta blockers. This medication is not recommended for use in children less than 2 years old due to an increased risk of serious side effects. Ask the doctor or pharmacist for more details. In 2024, this provider wrote 20 Medicare prescriptions for Brimonidine Tartrate-Timolol, about 66% of the volume of the typical Illinois prescriber of this medication (30.3). Medicare paid an average of $129.43 per fill, versus $177.49 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average IL prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the IL average for this medication. 29.3 30-Day Fills standardized to 30-day supplies 820 Days of Medication total across all patients in 2024 | |||
| RocklatanNetarsudil Mesylat/Latanoprost | 19 | $494.48▼ below IL avg | ▼ Less than typical |
About Rocklatan: Netarsudil/latanoprost is used to treat high pressure inside the eye due to certain eye conditions (such as open-angle glaucoma, ocular hypertension). Show more ▾ Lowering high pressure inside the eye can help prevent vision loss or blindness. In 2024, this provider wrote 19 Medicare prescriptions for Rocklatan, about half the volume of the typical Illinois prescriber of this medication (38.5). Medicare paid an average of $494.48 per fill, versus $540.50 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average IL prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the IL average for this medication. 25.9 30-Day Fills standardized to 30-day supplies 645 Days of Medication total across all patients in 2024 | |||
About this data. The prescription history for DZUNG X NGUYEN OD is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2024, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Optometrist prescribing approach at this Oak Lawn, IL practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average among IL prescribers of the same medication and form, shown only when at least five prescribers contribute. Always confirm current medications and costs directly with the provider and your plan.
About the medication summaries. Drug use descriptions come from the CMS Medicare Part D Drug Spending Dashboard (2024), and substance definitions from Medical Subject Headings (MeSH) 2026, U.S. National Library of Medicine. They are summaries that do not contain all possible information about a medication and are not individual medical advice. Ask a health care professional about any medication and your specific health needs.
